In this episode of Talking Health Tech, host Peter Birch catches up with Professor Clara Chow, a cardiologist and academic director of the Westmead Applied Research Centre (WARC). Clara shares insights into WARC's innovative work in addressing chronic diseases like cardiovascular diseases, diabetes, and lung disease using technology to improve healthcare delivery. The episode delves into the importance of evidence-based solutions in the healthcare space, the development of digital clinical trials, the launch of DigiCuris, and the potential impact on patient care in the future.

Key Takeaways:

1. Importance of Evidence-Based Solutions: Clara emphasises the significance of evidence-based solutions and the need to ensure that technology effectively improves health outcomes and patient experience, while being cost-effective.

2. Customised and Personalised Approach: WARC utilises simple, customised, and personalised digital technologies to support patients with a diverse range of chronic health conditions, ensuring that communication and support are accessible to everyone, regardless of language or technological proficiency.

3. Impact of Digital Clinical Trials: Clara discusses the positive impact of digital clinical trials on patients, highlighting the effectiveness of a text message-based education support program in improving health markers and patient adherence.

4. Development of DigiCuris: The launch of DigiCuris as a culmination of years of research learnings, aiming to deliver complex, personalised, and evidence-based healthcare programs to a wide range of patients, focusing on chronic health conditions.

Check out the episode and full show notes on the Talking HealthTech website.

Loving the show? Leave us a review, and share it with someone who might get some value from it. 

Keen to take your healthtech to the next level? Become a THT+ Member for access to our online community forum, quarterly summits, and more exclusive content. 

For more information visit talkinghealthtech.com/thtplus.